<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-04-20T02:16:52Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/2455-8583.000029">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/2455-8583.000029</identifier>
									<datestamp>2017-09-12</datestamp>
									<setSpec>PTZ.GJODMS:VOL4</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Serum Concentrations of Osteocalcin (OC) and Beta-Cross Laps (Beta-CTx) and Insulin Resistance in Morbid Obese Women with and without DM2
										</dc:title><dc:creator>Arrieta F</dc:creator><dc:creator> Iglesias P</dc:creator><dc:creator> Piñera M</dc:creator><dc:creator> Arrieta A4</dc:creator><dc:creator>Quiñones J</dc:creator><dc:creator> Balsa J</dc:creator><dc:creator>Vazquez C</dc:creator><dc:description>&lt;p&gt;&lt;strong&gt;Aim:&lt;/strong&gt; The present study was intended to establish the role of bone in grade III obese women with and without type 2 diabetes mellitus (T2DM).&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Material &amp;amp; Methods:&lt;/strong&gt; Serum osteocalcin (OC), Beta Cross-Laps (Beta-CTx), parathormone (PTH) separar and y 25-hydroxyvitamin D (25OHD) concentrations were measured in 48 morbid obesity women (11 with T2DM and 37 control group). Insulin resistance and insulin secretion was assessed by measuring the HOMA-IR and the HOMAβ index and its association with OC and Beta-CTx.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; Serum OC was significant lower in the diabetic group compared with non-diabetic patients 15.4 ± 3.6 ng/ml vs 22.1 ± 3.5 ng/ml, p&amp;lt;0.001 without significant differences in Beta-CTx (0.24 ± 0.1 vs 0.31 ± 0.2 ng/ml, ns). Both bone biomarkers, OC and Beta-CTx, showed a positive correlation (r=0.76; p&amp;lt;0.01) in the whole group subjects and in the control group (r=0.80, p&amp;lt;0.00), but no in the T2DM group (r=0.50, p ns). In the whole group of patients, OC correlated significantly with HOMA-IR (r=0.36; p&amp;lt;0.01) and HOMA-ß (r=0.36, p&amp;lt;0.01). Beta-CTx also correlated with HOMA-IR (r= 0.40, p&amp;lt;0.01) and HOMA-ß (r= 0.41, p&amp;lt;0.001. OC also significantly correlated with HOMA-IR (r=0.41, p&amp;lt;0.01) in non-diabetic patients and almost reached statistical significance with HOMA-ß (r=0.32, p=0.053), but was not significantly correlated with HOMA-ß (r= -0.53, ns) and with HOMA-IR index (r=0.52, ns) in the T2DM group. When we performed the multivariate logistic regression the serum level of OC was the only covariate found significantly with DM2 with a coeficient -6.65 , (95% CI, -12.75049 -.5674469 ); p = 0.03). Both groups showed secondary hyperparathyroidism (T2DM, 78.4 ± 19.4 pg/ml vs non-diabetic group, 75.4 ± 35.6 pg/ml; ns). The majority of the patients showed 25OHD deficiency 62.5%, followed by 25OHD insufficiency 27.1% and normal 25OHD levels in only 10.4%. The 25OHD deficiency was present in both study groups (T2DM patients, 18.3 ± 7.4 pg/ml and nondiabetic group, 19.7 ± 9.6 pg/ml; ns).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; OC and Beta-CTx could play a role in glucose metabolism and insulin resistance. Serum OC concentrations are significantly reduced in T2DM morbidily obese women compared with non-diabetic group, and add new evidence on the possible role of bone as an endocrine organ with metabolic implications specially the levels of OC.&lt;/p&gt;</dc:description>
										<dc:publisher>Global Journal of Obesity, Diabetes and Metabolic Syndrome - Peertechz Publications</dc:publisher>
										<dc:date>2017-09-12</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/2455-8583.000029</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Arrieta F et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
